Levobunolol ophthalmic Treatment Report : PatientsLikeMe

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Levobunolol ophthalmic Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Levobunolol ophthalmic?

Levobunolol is a a beta blocker antiglaucoma ophthalmic agent. It is used to lower intraocular pressure in chronic open-angle glaucoma or ocular hypertension.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Glaucoma (Both eyes)	1	0
Glaucoma	1	0

See all 3 patients currently taking Levobunolol ophthalmic

Mouse over the table for more information

Reported Dosages

0.5 g daily	1 g daily	2 g daily
1	1	1

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Taking Levobunolol ophthalmic

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	0	0	1

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.